ロード中...
Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent
Recently, new therapeutics have been developed for hepatocellular carcinoma (HCC). However, the overall survival rate of HCC patients is still unsatisfactory; one of the reasons for this is the high frequency of recurrence after radical treatment. Consequently, to improve prognosis, it will be impor...
保存先:
| 出版年: | Diseases |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5548248/ https://ncbi.nlm.nih.gov/pubmed/28943616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases3030150 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|